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Background
HIV-infected patients may be at increased risk of cardio-
vascular disease (CVD), and present higher carotid intima
media thickness (IMT) compared with healthy controls.
Besides clinical and metabolic factors, atherosclerosis in
HIV is influenced by immune and inflammatory parame-
ters. Given that T-cell activation correlates with CVD and
HIV accounts for heightened T-cell hyperactivation, we
hypothesized that early IMT increases associate to T-cell
hyperactivation.
Methods
We performed a cross-sectional correlation between
carotid IMT and immunological parameters on a cohort
of 71 HIV patients: 17 subjects had a positive history for
cardiovascular events (CE), 22 patients presented
increased IMT measurements (>1 mm, IIMT), and 32 had
normal IMT values (<1 mm, NIMT). No clinical signs of
CVD were shown in the IIMT and NIMT groups. Parame-
ters of T-cell homeostasis (CD127), activation
(CD38+CD8+) and death (CD95/Fas) were assessed by
flow cytometry. Plasma IL-6 and TNF-α levels were also
measured.
Summary of results
The three groups were comparable in terms of CVD risk
factors, and HIV-related viro-immunological parameters.
Major results are shown in Table 1. Compared to NIMT
subjects, CE patients presented higher activated
CD38+CD8+ (p = 0.01), lower CD95+CD8+ and
CD127+CD8+ cells (p = 0.03) and increased plasma IL-6
(p = 0.02) and TNF-α. Surprisingly, IIMT patients pre-
sented CD38+CD8+ proportions comparable to CE (p =
0.18), significantly higher than NIMT (p = 0.01), resulting
in a significant positive correlation between IMT and T-
cell activation (p = 0.04). Analogously, IIMT patients dis-
played CD95+CD8+ and CD127+CD8+ proportions
comparable to CE (p > 0.5), and significantly lower than
NIMT (p = 0.08 and p = 0.03, respectively).
Conclusion
Despite no overt sign of CVD, HIV-infected patients with
pathologic IMT increases display a peripheral T-cell
immune phenotype and activation similar to CVD
patients characterised by a highly activated/senescent,
pro-apoptotic T-cell pool. By showing specific T-cell pat-
terns associated to IMT increases, our findings support a
possible role of immunological parameters as early surro-
gate markers of CVD risk in HIV-infected patients.
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CE (n = 17) IIMT (n = 22) NIMT (n = 32)
Left carotid IMT (mm) 0,9 (0,6–1,26) 1,2 (0,6–1,86) 0,86 (0,6–0,9)
Right carotid IMT (mm) 0,92 (0,73–1,38) 1,24 (0,99–1,75) 0,89 (0,75–0,99)
CD38+CD8+ % 1,5 (1–8) 2 (1–6) 1 (0–6)
CD38+CD8+ n 20 (11–192) 28 (8–84) 16 (0–65)
CD95+CD8+ % 1 (1–9) 1 (1–9) 2 (1–3)
CD95+CD8+ n 22 (11–64) 24 (13–68) 26 (11–336)
CD127+CD8+ % 12 (8–21) 12 (5–23) 14 (8–23)
CD127+CD8+ n 173 (121–286) 202 (64–364) 247 (108–572)
IL-6 (pg/mL) 1,5 (0,2–2,2) 0,8 (0,4–7,4) 0,88 (0,24–8,3)
TNF-α (pg/mL) 3,2 (2,3–4,7) 1,6 (1,5–2,9) 1,5 (1,27–2,10)Page 2 of 2
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